Nancy Wyant

Nancy Wyant has extensive work experience in the pharmaceutical and biotechnology industry. Nancy currently serves as the SVP of Development Operations at Rapport Therapeutics since January 2023. Prior to this, they held roles at Stoke Therapeutics, starting as the Vice President of Development Operations in December 2018 and later being promoted to the SVP of Development Operations in March 2021 until January 2023.

Before joining Stoke Therapeutics, Nancy worked as an Independent Clinical Program Management and Operations Consultant from February 2018 to December 2018, where they held the position of Principal. From January 2017 to January 2018, they were the Vice President of Global Clinical Operations at BeiGene.

Earlier in their career, Nancy held leadership positions at Idera Pharmaceuticals as the Vice President of Clinical Operations from May 2014 to June 2016, and at Sarepta Therapeutics as the Head of Clinical Operations from January 2013 to May 2014.

Prior to that, they worked at Shire Pharmaceuticals - HGT as the Sr. Director of Clinical & Medical Affairs Operations from March 2009 to December 2012, and as the Director of Clinical Compliance from January 2006 to March 2009. Before Shire Pharmaceuticals, Nancy also gained experience at Transkaryotic Therapies, Inc as the Manager of Clinical Operations from October 2003 to January 2006, at Therion Biologics as the Manager of Clinical Operations from November 2002 to October 2003, and at Vertex Pharmaceuticals as a Sr. Clinical Operations Coordinator from 1998 to 2002.

Nancy Wyant obtained a Bachelor of Arts degree in Psychology from Hartwick College, studying from 1989 to 1993.